<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0376-7892</journal-id>
<journal-title><![CDATA[Cirugía Plástica Ibero-Latinoamericana]]></journal-title>
<abbrev-journal-title><![CDATA[Cir. plást. iberolatinoam.]]></abbrev-journal-title>
<issn>0376-7892</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Cirugía Plástica, Reparadora y Estética (SECPRE)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0376-78922020000300003</article-id>
<article-id pub-id-type="doi">10.4321/s0376-78922020000300003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Tendencia en el uso de implantes mamarios de los cirujanos plásticos iberolatinoamericanos. Estudio FILACP 2010-2020]]></article-title>
<article-title xml:lang="en"><![CDATA[Trend in the use of breast implants of Ibero Latin American plastic surgeons. FILACP study 2010-2020]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sainz-Arregui]]></surname>
<given-names><![CDATA[José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vaquero Pérez]]></surname>
<given-names><![CDATA[María del Mar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Bilbao  ]]></institution>
<addr-line><![CDATA[Bilbao ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Madrid  ]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2020</year>
</pub-date>
<volume>46</volume>
<numero>2</numero>
<fpage>125</fpage>
<lpage>140</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0376-78922020000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0376-78922020000300003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0376-78922020000300003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción y objetivo.  Desde su creación en 2010, el Comité de Registro de Implantes de la FILACP (Federación Ibero Latinoamericana de Cirugía Plástica), entidad internacional que agrupa a los 22 Sociedades Nacionales de Cirugía Plástica de habla hispana y portuguesa, ha trabajando para conocer las preferencias y usos habituales entre sus miembros en la cirugía de aumento mamario con implantes. Con ese objetivo, realizó entre 2010 y 2020 una serie de encuestas periódicas para investigar las variables implicadas en la cirugía mamaria con implantes llevada a cabo por los cirujanos plásticos de Ibero Latinoamérica y la forma en que pudiera haber influido en ellos la incidencia del linfoma anaplásico de células grandes asociado a implantes mamarios (LACG-AIM) y su posible relación etiopatogénica con determinados tipos de implantes. Presentamos en este artículo los datos obtenidos y analizamos las tendencias observadas.  Material y método. Estudio comparativo de datos recogidos en 4 encuestas enviadas a 5000 miembros de la FILACP: la primera presentada en 2012, con 25 preguntas sobre cirugía mamaria primaria con implantes y 18 sobre cirugía secundaria; la segunda presentada en 2016 con 31 preguntas sobre cirugía primaria y 52 sobre cirugía secundaria; la tercera en 2018 con 40 preguntas tanto de cirugía primaria como secundaria; y la cuarta en 2020, con 13 preguntas generales.  Resultados.  Los datos recogidos reflejan una preferencia de los cirujanos plásticos iberolatinoamericanos por el uso de implantes redondos, con tendencia al incremento del uso de los de cubierta lisa frente a los texturizados, con abordaje quirúrgico preferencial por vía periareolar, colocación en plano submuscular, y una concienciación creciente de la necesidad de realizar capsulectomía quirúrgica en las cirugías secundarias y del envío de la cápsula extirpada a estudio anatomopatológico. Refieren también un buen conocimiento del LACG-AIM y de las variables implicadas en su diagnóstico y tratamiento. Recogemos también a fecha abril de 2020 los casos de LACG-AIM notificados por las Sociedades Nacionales de la FILACP: 106 casos en 9 países, con 2 fallecimientos.  Conclusiones.  La tendencia entre nuestros encuestados, seguramente influidos por el conocimiento de los factores relacionados con la etiología del LACG-AIM, va hacia el uso cada vez más mayoritario de implantes de cubierta lisa y de forma redonda, y representa una estimación importante y actualizada de los usos de un colectivo profesional muy representativo en un entorno internacional que suele recoger solo datos de profesionales y publicaciones anglosajonas]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Backgraund and objective.  Since its creation in 2010, the Implant Registry Committee of FILACP (Ibero Latin American Federation of Plastic Surgery) an international entity that gathers the 22 National Societies of Plastic Surgery of Spanish and Portuguese language, has worked to know the common preferences and uses among its members in breast augmentation surgery with implants. With this aim, between 2010 and 2020, it carried out a series of periodic surveys to investigate the variables involved in breast surgery with implants carried out by plastic surgeons from Iberolatinamerica and how the incidence of breast implants associated anaplastic large cell lymphoma (BIA-ALCL) and its possible etiopathogenic relationship with certain types of implants might have influenced them. We present in this article the data obtained and analyze the observed trends.  Methods.  Comparative study of data collected in 4 surveys sent to 5000 FILACP members: the first one presented in 2012, with 25 questions on primary breast surgery with implants and 18 on secondary surgery; the second one presented in 2016 with 31 questions on primary surgery and 52 on secondary surgery; the third one in 2018 with 40 questions on both primary and secondary surgery; and the fourth one in 2020, with 13 general questions.  Results.  General data reflects a preference of Iberolatinamerican plastic surgeons for the use of round implants, with a tendency to increase the use of smooth cover versus textured implants, with a preferential surgical periareolar approach, submuscular placement, and awareness growing need for surgical capsulectomy in secondary surgeries, and for the pathology study of the removed capsule. They also report a good knowledge of BIA-ALCL and the variables involved in its diagnosis and treatment. As of April 2020, we also collected the cases of BIA-ALCL reported by the FILACP National Societies: 106 cases in 9 countries, with 2 deaths.  Conclusions.  The trend among our respondents, surely influenced by the knowledge of the factors related to the etiolo- gy of BIA-ALCL, is towards the increasing use of smooth and round-shaped implants, and represents an important and updated estimate of the uses of a highly representative professional collective in an international environment that usually collects only data from anglo-saxon professionals and publications.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Implantes mamarios]]></kwd>
<kwd lng="es"><![CDATA[Aumento mamario]]></kwd>
<kwd lng="es"><![CDATA[LACG-AIM]]></kwd>
<kwd lng="es"><![CDATA[Encuestas]]></kwd>
<kwd lng="en"><![CDATA[Breast implants]]></kwd>
<kwd lng="en"><![CDATA[Breast augmentation]]></kwd>
<kwd lng="en"><![CDATA[BIA-ALCL]]></kwd>
<kwd lng="en"><![CDATA[Survey]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Phil]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Roth]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[K.C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anaplastic Large Cell Lymphoma and Breast Implants: A Systematic Review]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2011</year>
<volume>127</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2141-50</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brody]]></surname>
<given-names><![CDATA[G.S]]></given-names>
</name>
<name>
<surname><![CDATA[Deapen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[C.R]]></given-names>
</name>
<name>
<surname><![CDATA[Phil]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases]]></article-title>
<source><![CDATA[Plas. Rec Surg]]></source>
<year>2015</year>
<volume>135</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>695-705</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Srinivasa]]></surname>
<given-names><![CDATA[D.R]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[R.N]]></given-names>
</name>
<name>
<surname><![CDATA[Kaura]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Francis]]></surname>
<given-names><![CDATA[A.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global Adverse Event Reports of Breast Implant-Associated ALCL: An International Review of 40 Government Authority Databases]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2017</year>
<volume>139</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1029-39</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Doren]]></surname>
<given-names><![CDATA[E.L]]></given-names>
</name>
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[R.N]]></given-names>
</name>
<name>
<surname><![CDATA[Selber]]></surname>
<given-names><![CDATA[J.C]]></given-names>
</name>
<name>
<surname><![CDATA[Garvey]]></surname>
<given-names><![CDATA[P.B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[US. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2017</year>
<volume>139</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1042-50</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Boer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[van Leeuwen]]></surname>
<given-names><![CDATA[F.E]]></given-names>
</name>
<name>
<surname><![CDATA[Hauptmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Overbeek]]></surname>
<given-names><![CDATA[L.I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast]]></article-title>
<source><![CDATA[JAMA Oncology]]></source>
<year>2018</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>335-41</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>Agencia Española de Medicamentos y Productos Sanitarios AEMPS</collab>
<source><![CDATA[Cese de la comercialización y de la utilización de determinados implantes mamarios de la empresa Allergan. 2018, 19 de diciembre, Referencia 26/2018]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Allergan plc (NYSE: AGN)</collab>
<source><![CDATA[Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hidalgo]]></surname>
<given-names><![CDATA[D.A]]></given-names>
</name>
<name>
<surname><![CDATA[Sinno]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current Trends and Controversies in Breast Augmentation]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2016</year>
<volume>137</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1142-50</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benito Ruiz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implantes mamarios en España: resultados de encuesta a cirujanos plásticos]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2017</year>
<volume>43</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>239-46</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<collab>ISAPS</collab>
<source><![CDATA[International Survey on Aesthetic/Cosmetic Procedures]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>ISAPS</collab>
<source><![CDATA[International Survey on Aesthetic/Cosmetic Procedures]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gilbert]]></surname>
<given-names><![CDATA[D.N]]></given-names>
</name>
<name>
<surname><![CDATA[Eliopoulos]]></surname>
<given-names><![CDATA[G.M]]></given-names>
</name>
<name>
<surname><![CDATA[Chambers]]></surname>
<given-names><![CDATA[H.F]]></given-names>
</name>
<name>
<surname><![CDATA[Saag]]></surname>
<given-names><![CDATA[M.S]]></given-names>
</name>
</person-group>
<source><![CDATA[Sanford Guide to Antimicrobial Therapy]]></source>
<year>2014</year>
<publisher-name><![CDATA[Sanford Guide Ed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>WHO</collab>
<source><![CDATA[Who global guidelines for the prevention of surgical site infection]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avellaneda]]></surname>
<given-names><![CDATA[E.M]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Gómez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pacheco Compaña]]></surname>
<given-names><![CDATA[F.J]]></given-names>
</name>
<name>
<surname><![CDATA[Comellas Melero]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis de la utilización de un protocolo de profilaxis antibiótica en cirugía mamaria]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2016</year>
<volume>42</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>255-64</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clayton]]></surname>
<given-names><![CDATA[J.L]]></given-names>
</name>
<name>
<surname><![CDATA[Tazakas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[C.N]]></given-names>
</name>
<name>
<surname><![CDATA[Hultman]]></surname>
<given-names><![CDATA[C.S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Once is not enough: Withholding postoperative prophylactic antibiotics in prosthetic breast reconstruction is associated with an increased risk of infection]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2012</year>
<volume>130</volume>
<page-range>495-502</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adams Jr]]></surname>
<given-names><![CDATA[W.P]]></given-names>
</name>
<name>
<surname><![CDATA[Culbertson]]></surname>
<given-names><![CDATA[E.J]]></given-names>
</name>
<name>
<surname><![CDATA[Deva]]></surname>
<given-names><![CDATA[A.K]]></given-names>
</name>
<name>
<surname><![CDATA[Magnusson]]></surname>
<given-names><![CDATA[M.R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Macrotextured Breast Implants With Defined Steps to Minimize Bacterial Contamination Around the Device: Experience in 42,000 Implants]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2017</year>
<volume>140</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>427-31</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tandon]]></surname>
<given-names><![CDATA[V.J]]></given-names>
</name>
<name>
<surname><![CDATA[De Long]]></surname>
<given-names><![CDATA[M.R]]></given-names>
</name>
<name>
<surname><![CDATA[Ballard]]></surname>
<given-names><![CDATA[T.N]]></given-names>
</name>
<name>
<surname><![CDATA[Clemens]]></surname>
<given-names><![CDATA[M.W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolving Trends in Textured Implant Use for Cosmetic Augmentation in the United States]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2018</year>
<volume>142</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1456-61</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clemens]]></surname>
<given-names><![CDATA[M.W]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobsen]]></surname>
<given-names><![CDATA[E.D]]></given-names>
</name>
<name>
<surname><![CDATA[Horwitz]]></surname>
<given-names><![CDATA[S.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)]]></article-title>
<source><![CDATA[Aesth Surg J.]]></source>
<year>2019</year>
<volume>39</volume>
<numero>S1</numero>
<issue>S1</issue>
<page-range>S3-S13</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Largent]]></surname>
<given-names><![CDATA[J.A]]></given-names>
</name>
<name>
<surname><![CDATA[Reisman]]></surname>
<given-names><![CDATA[N.R]]></given-names>
</name>
<name>
<surname><![CDATA[Kaplan]]></surname>
<given-names><![CDATA[H.M]]></given-names>
</name>
<name>
<surname><![CDATA[Oefelein]]></surname>
<given-names><![CDATA[M.G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Trial Outcomes of High- And Extra High-Profile Breast Implants]]></article-title>
<source><![CDATA[Aesthet Surg J]]></source>
<year>2013</year>
<volume>33</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>529-39</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[J.N]]></given-names>
</name>
<name>
<surname><![CDATA[Pinkner]]></surname>
<given-names><![CDATA[C.I]]></given-names>
</name>
<name>
<surname><![CDATA[Pinkner]]></surname>
<given-names><![CDATA[J.S]]></given-names>
</name>
<name>
<surname><![CDATA[Hultgren]]></surname>
<given-names><![CDATA[S.J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The detection of bacteria and matrix proteins on clinically benign and pathologic implants]]></article-title>
<source><![CDATA[Plast Rec Surg. Global Open]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rastogi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Riordan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Deva]]></surname>
<given-names><![CDATA[A.K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Theories of Etiopathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2019</year>
<volume>143</volume>
<numero>3S</numero>
<issue>3S</issue>
<page-range>23S-9S</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>Agence Nationale de Sécurité du Medicament et de Prosuits de Santé (ANSM)</collab>
<source><![CDATA[Retirer du marché des implants mammaires macrotexturés et des implants mammaires à surface recouverte de polyuréthane - Communiqué 04/04/2019]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<collab>Australian Government, Department of Health</collab>
<source><![CDATA[Update outcomes from de TGA´s review of breast implants and breast tissue expander]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mempin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The functional influence of breast implant outer shell morphology on bacterial attachment and growth]]></article-title>
<source><![CDATA[Plast Reconstr Surg]]></source>
<year>2018</year>
<volume>142</volume>
<page-range>837-49</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clemens]]></surname>
<given-names><![CDATA[M.W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma anaplásico de células grandes asociado a implantes mamarios (LACG-AIM): capeando los desafíos de un clima rápidamente cambiante]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2019</year>
<volume>45</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>215-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Di Napoli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Achieving reliable diagnosis in late breast implant seroma: from reactive to anaplastic large cell lymphoma]]></article-title>
<source><![CDATA[Plast Rec Surg]]></source>
<year>2019</year>
<volume>143</volume>
<numero>3S</numero>
<issue>3S</issue>
<page-range>15S-22S</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brody]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Deapen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[T-CELL Non Hodgkins Anaplastic Lymphoma Associated With One Style Of Breast Implant]]></source>
<year>2010</year>
<conf-name><![CDATA[ AAPS-89th Annual Meeting Abstracts]]></conf-name>
<conf-date>2010</conf-date>
<conf-loc> </conf-loc>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres Rivero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos Gallardo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Nambo Lucio]]></surname>
<given-names><![CDATA[M.J]]></given-names>
</name>
<name>
<surname><![CDATA[Vaquero Pérez]]></surname>
<given-names><![CDATA[M.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primer caso en México y América Latina de linfoma anaplásico de células gigantes en paciente con implantes mamarios]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2016</year>
<volume>42</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>175-80</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Sobrino]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Cordones Guerrero]]></surname>
<given-names><![CDATA[J.J]]></given-names>
</name>
<name>
<surname><![CDATA[Benítez Dupin]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Masa palpable como presentación atípica de linfoma anaplásico de células gigantes asociado a implantes mamarios]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2017</year>
<volume>43</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>129-35</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Umaña Ordóñez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Recalde Losada]]></surname>
<given-names><![CDATA[C.A]]></given-names>
</name>
<name>
<surname><![CDATA[Rubio Verdú]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma anaplásico de células grandes asociado a implantes mamarios. Cuatro casos diagnosticados en la provincia de Alicante, España]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2019</year>
<volume>45</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>225-34</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vera García]]></surname>
<given-names><![CDATA[P.J]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno Villalba]]></surname>
<given-names><![CDATA[R.A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Pascual]]></surname>
<given-names><![CDATA[C.J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primer caso en la Región de Murcia (España) de linfoma anaplásico de células grandes asociado a implantes mamarios]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2019</year>
<volume>45</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>235-42</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casado Sánchez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Córdoba Chicote]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez Franjo]]></surname>
<given-names><![CDATA[M.P]]></given-names>
</name>
<name>
<surname><![CDATA[Vaquero Pérez]]></surname>
<given-names><![CDATA[M.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Limitaciones diagnósticas de las determinaciones inmunohistoquímicas preoperatorias en el linfoma anaplásico de células grandes asociado a implante mamario (LACG-AIM)]]></article-title>
<source><![CDATA[Cir plást iberolatinoam]]></source>
<year>2019</year>
<volume>45</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>243-52</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Collett]]></surname>
<given-names><![CDATA[D.J]]></given-names>
</name>
<name>
<surname><![CDATA[Rakhorst]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lennox]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Magnusson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants]]></article-title>
<source><![CDATA[Plast. Rec. Surg.]]></source>
<year>2019</year>
<volume>143</volume>
<numero>3S</numero>
<issue>3S</issue>
<page-range>30S-40S</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
